Abstract
For more than a decade, prostate-specific antigen (PSA) has been used for prostate cancer screening. Over the years, this screening has been continually refined, including investigation into the use of lower total PSA thresholds, PSA isoforms, and PSA kinetics. This review describes the evolution of prostate cancer screening and provides clinical insights into the informed use of PSA and its adjunctive measurements. ©AlphaMed Press.
Cite
CITATION STYLE
APA
Loeb, S., & Catalona, W. J. (2008). What to Do with an Abnormal PSA Test. The Oncologist, 13(3), 299–305. https://doi.org/10.1634/theoncologist.2007-0139
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free